Keyphrases
Active Patient
33%
Anti-SARS-CoV-2 Antibodies
33%
Antibody Persistence
100%
Autoimmune Rheumatic Diseases
33%
CoronaVac
100%
Geometric Mean Titer
33%
Immunocompromised Patients
100%
Immunogenicity
33%
Inactivated SARS-CoV-2 Vaccine
33%
Logistic Regression Model
33%
Neutralizing Antibodies
66%
Physical Activity
100%
Physically Active
66%
Point Estimate
33%
Prospective Cohort Study
33%
Second Dose
100%
Seroconversion Rate
66%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
33%
Two-dose Schedule
33%
Vaccination
33%
Vaccine Trial
33%
Medicine and Dentistry
Arm
33%
Autoimmune Rheumatic Disease
33%
COVID-19 Vaccine
33%
Drug Dose Regimen
33%
Immunocompromised Patient
100%
Immunogenicity
33%
Logistic Regression Analysis
33%
Neutralizing Antibody
66%
Physical Activity
100%
Prospective Cohort Study
33%
SARS Coronavirus
33%
Seroconversion
66%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Immunology and Microbiology
Arm
33%
Autoimmune Rheumatic Disease
33%
Drug Dose Regimen
33%
Immunocompromised Patient
100%
Immunogenicity
33%
Neutralizing Antibody
66%
Physical Activity
100%
SARS Coronavirus
33%
Seroconversion
66%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Titer
33%
Nursing and Health Professions
Drug Dose Regimen
33%
Immunocompromised Patient
100%
Logistic Regression Analysis
33%
Neutralizing Antibody
66%
Prospective Cohort Study
33%
Rheumatic Disease
33%
Severe Acute Respiratory Syndrome
100%
Mathematics
Geometric Mean
100%
Logistic Regression Model
100%
Point Estimate
100%